These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2954381)

  • 1. [Effects of clofibrate, silybin, safflower oil and lamindran on liver peroxisome proliferation and enzyme activities in rats].
    Wu SG; Shen YA; Zheng Z; Long K
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):283-4. PubMed ID: 2954381
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 3. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental transfer of the hypolipidemic drug, clofibrate, induces CYP4A expression in 18.5-day fetal rats.
    Simpson AE; Brammar WJ; Pratten MK; Cockcroft N; Elcombe CR
    Drug Metab Dispos; 1996 May; 24(5):547-54. PubMed ID: 8723735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment.
    Hollinshead M; Meijer J
    Eur J Cell Biol; 1988 Aug; 46(3):394-402. PubMed ID: 3181162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of xanthine dehydrogenase in rat liver in response to peroxisome proliferators.
    Satoh A; Sasago S; Takahashi S; Kato N
    Biochem Biophys Res Commun; 1993 Sep; 195(2):751-7. PubMed ID: 8373410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on the actions of silybin on regenerating rat liver. Effects on Kupffer's cells.
    Magliulo E; Scevola D; Carosi GP
    Arzneimittelforschung; 1979; 29(7):1024-8. PubMed ID: 582993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
    Butler EG; England PJ; Williams GM
    Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):125-8. PubMed ID: 3381006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroxisomes and hypolipidemic agents ].
    Heller F; Pourbaix S
    Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
    Périchon R; Bourre JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):475-80. PubMed ID: 8595387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-influenced CPIB-induction of peroxisomes in rat liver and kidney tissues.
    Henry EW; DeMorrow JM
    Cytobios; 1985; 42(169S):279-93. PubMed ID: 4028834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
    Warren JR; Simmon VF; Reddy JK
    Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clofibrate on flow cytometric populations in rat liver.
    Tomioka Y; Suzuki H; Miura K; Yamaguchi T; Hishinuma T; Mizugaki M
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):189-95. PubMed ID: 8738070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of silybin from Silybum marianum (L.) Gaertn. on in vitro phosphatidyl choline biosynthesis in rat livers.
    Schriewer H; Weinhold F
    Arzneimittelforschung; 1979; 29(5):791-2. PubMed ID: 582978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.